Alivus Life Sciences discloses a one-on-one virtual investor meeting with Karma Capital scheduled for May 22, 2026.
The intimation is made pursuant to SEBI Listing Regulations 30 and Schedule III.
The company notes that the meeting schedule is subject to change due to exigencies.